http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2056276-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_552948600b07278d871438d3f62628d9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-54 |
| filingDate | 1980-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1984-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1984-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-2056276-B |
| titleOfInvention | Formulation of rifamycin sv and salts derived therefrom for treating rheumatoid arthritis |
| priorityDate | 1979-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324616 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426098818 |
Total number of triples: 13.